logo
CDC investigating hospitalizations of five people who recently received chikungunya vaccine

CDC investigating hospitalizations of five people who recently received chikungunya vaccine

CNN27-02-2025

The US Centers for Disease Control and Prevention is currently investigating five hospitalizations that occurred in people who had recently received a vaccine that prevents disease caused by the chikungunya virus.
In a notice posted Tuesday on a vaccine information page for health-care providers, the CDC said that the people, all 65 and older, were hospitalized for cardiac or neurologic events following vaccination with IXCHIQ, the only chikungunya vaccine currently licensed in the United States.
CNN has reached out to the CDC for comment.
Chikungunya virus is typically spread to people through the bite of an infected mosquito. Most adults don't receive the vaccine; it is sometimes recommended for certain travelers at an increased risk of being exposed to the mosquito-borne disease.
'This topic will be discussed at an upcoming meeting of the Advisory Committee on Immunization Practices (ACIP). Healthcare providers should discuss the benefits and risks of vaccination with individual travelers based on their age, destination, trip duration, and planned activities,' the CDC's online notice said in part.
The chikungunya vaccine and surveillance for adverse events originally were scheduled to be discussed in an ACIP meeting Wednesday, according to a draft meeting agenda, but that meeting has been postponed.
Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center and ACIP liaison, said the CDC investigation is an example of the agency's vaccine surveillance system 'working excellently and sending out a signal' in detecting rare events that might deserve further investigation.
'And of course, the CDC and the local people who are taking care of these patients are working on that now, which is entirely appropriate. That's the way the system is supposed to work,' Schaffner said.
'Remember, we're still trying to work out whether this is a causal relationship or a coincidental one,' he said about the investigation, in which he is not directly involved. 'Let's not draw any conclusions yet. That's why they're doing the investigation.'
The IXCHIQ vaccine, administered as a single-dose shot into the muscle, contains a live, weakened version of the chikungunya virus. The vaccine, manufactured by the biotechnology company Valneva, was the first vaccine approved by the US Food and Drug Administration to prevent disease caused by chikungunya virus. The approval, in November 2023, was for people 18 and older who are at increased risk of exposure to chikungunya virus.
'It's recommended in a very restricted way to travelers who are going to countries where there is a current outbreak of chikungunya virus infection, and also to travelers who are going to countries who had experienced an outbreak within the past five years,' Schaffner said. 'And also to laboratorians who work with the chikungunya virus in the laboratory.'
CNN has reached out to Valneva for comment. Prescribing information for the vaccine states, 'Vaccination with IXCHIQ may cause severe or prolonged chikungunya-like adverse reactions.'
Chikungunya virus circulates in tropical and subtropical regions. In the United States, locally acquired infections have not been reported since 2019, according to the CDC. But cases and outbreaks had been identified in more than 100 countries in the Americas, Africa, Asia, Europe, and the Indian and Pacific Oceans.
Symptoms of chikungunya infections include fever, joint pain, headache, muscle pain, joint swelling or rash, according to the CDC, and the best way to prevent chikungunya is to avoid mosquito bites. There are currently no medications to treat chikungunya, but infected people may feel better with rest, fluids and over-the-counter medications for pain and fever.
In Tuesday's notice, the CDC said that common adverse reactions following vaccination that occurred in more than 10% of vaccinated people in clinical trials included tenderness, headache, fatigue, muscle pain, joint pain, fever and nausea. In some people, 'severe or prolonged chikungunya-like adverse reactions' occurred.
Chikungunya-like reactions included 'fever, joint pain, headache, rash, and can also include cardiac and neurologic conditions which were serious in two cases,' Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, who was not involved in the clinical studies, said in an email Wednesday.
The CDC's notice encouraged health-care providers 'to report all adverse events that might be caused by vaccination to the CDC/FDA Vaccine Adverse Events Reporting System (VAERS),' by submitting a report online or using a PDF form.
'The robust vaccine safety surveillance system often identifies extremely rare adverse effects of vaccines after approval,' said Barouch, an infectious disease expert not involved in the CDC investigation.
When the vaccine was approved in 2023, the FDA noted that its safety was evaluated in two clinical studies conducted in North America in which about 3,500 adults received a dose of the vaccine, with one study including about 1,000 participants who received a placebo. Severe chikungunya-like adverse reactions occurred in 1.6% of IXCHIQ recipients and none of the placebo recipients, according to the FDA.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Global Healthy Living Foundation Says Vaccine Committee Firings Before Respiratory Virus Season Creates High Risk Of Illness In the Chronic Disease Community
Global Healthy Living Foundation Says Vaccine Committee Firings Before Respiratory Virus Season Creates High Risk Of Illness In the Chronic Disease Community

Yahoo

time40 minutes ago

  • Yahoo

Global Healthy Living Foundation Says Vaccine Committee Firings Before Respiratory Virus Season Creates High Risk Of Illness In the Chronic Disease Community

HHS Interrupts "The Most Cost-Beneficial Intervention In Healthcare" UPPER NYACK, N.Y., June 10, 2025--(BUSINESS WIRE)--Yesterday, the Secretary of Health and Human Services (HHS) removed all sitting members of the Advisory Committee on Immunization Practices (ACIP), the expert panel that advises the Centers for Disease Control and Prevention (CDC) on vaccine use. While the groups such as the Global Healthy Living Foundation (GHLF) recognize the Secretary's right to do this, the decision made just ahead of the upcoming respiratory virus season puts at risk chronically ill patients who rely on vaccines to fight respiratory virus infections. ACIP is often critical in shaping public health strategies with its advisory recommendations. While the FDA-approved label remains the definitive, enforceable standard for how vaccines should be used in clinical practice, ACIP guidance often informs insurance company coverage, determines whether vaccines are free under the Affordable Care Act, provides healthcare provider protocols, and helps ensure vaccination campaign success , especially for vulnerable populations. "Removing the entire committee without immediate replacement or clear guidance creates uncertainty when COVID-19, flu, and RSV are expected to circulate widely in the coming months," said Robert, Popovian, PharmD, MS, GHLF's Chief Science Policy Officer. "Now is the time when the advisory committee makes its recommendations, and disruption in the advisory process could have profound implications for individuals with chronic illnesses who depend on timely vaccine access to protect themselves against these viruses. "We support the need for ACIP to remain independent, and we recognize the Secretary's authority to appoint new members," Dr. Popovian added. "But removing all members without naming successors or offering a timeline to replace them so close to respiratory season could delay essential recommendations. "Vaccines are the most cost-beneficial intervention in healthcare—we should do everything possible to maintain uninterrupted access to expert guidance including ensuring there is no gap in expert advice during this critical period for immunization planning," Dr. Popovian added. About GHLF The Global Healthy Living Foundation is a U.S. based, 501(c)(3) nonprofit, international organization whose mission is to improve the quality of life for people with chronic illnesses by advocating for improved access to health care through education, patient-centered clinical research, support, advocacy, and economic and policy research. GHLF is also a staunch advocate for vaccines. The Global Healthy Living Foundation is the parent organization of CreakyJoints®, the international, digital community for millions of people living with arthritis and their supporters worldwide who seek education, support, activism, and patient-centered research in English, Spanish, and French. In addition to arthritis and autoimmune disorders, GHLF supports dermatology, gastroenterology, neurology, cardiology, oncology, infectious disease, rare disease, and pulmonary patients through a host of different programs and activities which draw more than 700,000 patients a month to GHLF websites and create more than 10 million impressions a month on seven social media platforms. In 2024, GHLF had more than 1 million views and listens with its patient-centered audio-visual content, found on YouTube and podcast platforms. GHLF never asks the public for donations, receiving funding instead through governments, non-governmental organizations, foundations, industry, family foundations, and GHLF Co-Founder Louis Tharp. Visit for more information. View source version on Contacts Louis TharpLTHARP@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Global Healthy Living Foundation Says Vaccine Committee Firings Before Respiratory Virus Season Creates High Risk Of Illness In the Chronic Disease Community
Global Healthy Living Foundation Says Vaccine Committee Firings Before Respiratory Virus Season Creates High Risk Of Illness In the Chronic Disease Community

Business Wire

timean hour ago

  • Business Wire

Global Healthy Living Foundation Says Vaccine Committee Firings Before Respiratory Virus Season Creates High Risk Of Illness In the Chronic Disease Community

BUSINESS WIRE)--Yesterday, the Secretary of Health and Human Services (HHS) removed all sitting members of the Advisory Committee on Immunization Practices (ACIP), the expert panel that advises the Centers for Disease Control and Prevention (CDC) on vaccine use. Vaccines are the most cost-beneficial intervention in healthcare While the groups such as the Global Healthy Living Foundation (GHLF) recognize the Secretary's right to do this, the decision made just ahead of the upcoming respiratory virus season puts at risk chronically ill patients who rely on vaccines to fight respiratory virus infections. ACIP is often critical in shaping public health strategies with its advisory recommendations. While the FDA-approved label remains the definitive, enforceable standard for how vaccines should be used in clinical practice, ACIP guidance often informs insurance company coverage, determines whether vaccines are free under the Affordable Care Act, provides healthcare provider protocols, and helps ensure vaccination campaign success , especially for vulnerable populations. 'Removing the entire committee without immediate replacement or clear guidance creates uncertainty when COVID-19, flu, and RSV are expected to circulate widely in the coming months,' said Robert, Popovian, PharmD, MS, GHLF's Chief Science Policy Officer. 'Now is the time when the advisory committee makes its recommendations, and disruption in the advisory process could have profound implications for individuals with chronic illnesses who depend on timely vaccine access to protect themselves against these viruses. 'We support the need for ACIP to remain independent, and we recognize the Secretary's authority to appoint new members,' Dr. Popovian added. 'But removing all members without naming successors or offering a timeline to replace them so close to respiratory season could delay essential recommendations. 'Vaccines are the most cost-beneficial intervention in healthcare—we should do everything possible to maintain uninterrupted access to expert guidance including ensuring there is no gap in expert advice during this critical period for immunization planning,' Dr. Popovian added. About GHLF The Global Healthy Living Foundation is a U.S. based, 501(c)(3) nonprofit, international organization whose mission is to improve the quality of life for people with chronic illnesses by advocating for improved access to health care through education, patient-centered clinical research, support, advocacy, and economic and policy research. GHLF is also a staunch advocate for vaccines. The Global Healthy Living Foundation is the parent organization of CreakyJoints®, the international, digital community for millions of people living with arthritis and their supporters worldwide who seek education, support, activism, and patient-centered research in English, Spanish, and French. In addition to arthritis and autoimmune disorders, GHLF supports dermatology, gastroenterology, neurology, cardiology, oncology, infectious disease, rare disease, and pulmonary patients through a host of different programs and activities which draw more than 700,000 patients a month to GHLF websites and create more than 10 million impressions a month on seven social media platforms. In 2024, GHLF had more than 1 million views and listens with its patient-centered audio-visual content, found on YouTube and podcast platforms. GHLF never asks the public for donations, receiving funding instead through governments, non-governmental organizations, foundations, industry, family foundations, and GHLF Co-Founder Louis Tharp. Visit for more information.

HHS budget proposal eliminates CDC's chronic disease, global health centers in favor of new "MAHA" agency
HHS budget proposal eliminates CDC's chronic disease, global health centers in favor of new "MAHA" agency

CBS News

timean hour ago

  • CBS News

HHS budget proposal eliminates CDC's chronic disease, global health centers in favor of new "MAHA" agency

The Department of Health and Human Services' budget request for the 2026 fiscal year consolidates the department's 28 divisions to 15 to make way for a new "institution of public health." The new agency, the Administration for a Healthy America, has a $20.6 billion budget designed to support Health Secretary Robert F. Kennedy Jr.'s "Make America Healthy Again" agenda. That includes taking over — and significantly reducing — funds for the Centers for Disease Control and Prevention's chronic disease and global health centers along with some of the institutes that are currently part of the National Institutes of Health. The Administration for a Healthy America, or AHA, says it will take a "root cause" approach to chronic disease prevention, according to the agency's budget request, released last Friday. But the budget proposes cutting funding for all programs in the CDC's chronic disease center and would make significant cuts to existing primary care, mental health and environmental health programs. The cuts slash the CDC's budget from nearly $9.2 billion in FY 2024 to $4.2 billion. At least 20%, or $1 billion, of the funding cut is moving to AHA. The cuts will have a trickle-down effect on states and cities. The vast majority of CDC funding is discretionary and funneled to state and local health departments. Last year, these departments received $4.5 billion of CDC funding to "promote and protect health in their communities." And even where funds are maintained, the restructuring could come at a cost, according to Richard Frank, director of the Center on Health Policy at the Brookings Institution. "The CDC has over the years developed a lot of human capital," Frank said. The agency's infectious disease response, involving surveillance and expert teams sent to the source of an outbreak, is "not something you learn overnight that you can just move around easily without disrupting how effective it is." The budget request also cuts the NIH by about 40% and dissolves agencies including the Substance Abuse and Mental Health Services Administration and the Health Resources Service Administration. "The Budget reflects needed reforms to put health care spending on a sustainable fiscal path and proposes policies to Make America Healthy Again," HHS press secretary Emily Hilliard wrote in a statement to CBS News. "The United States remains the sickest developed nation despite spending $4.5 trillion annually on health care, resulting in an exploding debt that poses a critical threat to our country along with worsening health outcomes." Kennedy has repeatedly decried the "childhood chronic disease crisis" in America. That was a central focus of his "Make America Healthy Again" commission report. The report has been criticized for citing studies that do not exist, including false information and omitting established drivers of chronic disease in children that health authorities are already working to address. Chronic disease prevention The latest budget request would eliminate the CDC's Center for Chronic Disease Prevention and Health Promotion, for which $1.4 billion was appropriated in FY 2024. Instead, AHA would fund primary care, environmental health, mental health and nutrition programs. This, according to the department, would prevent chronic disease from the source, rather than fund individual programs on cancer, diabetes, heart disease and other diseases as the CDC's chronic disease center did. Nearly 70 organizations, including the American Heart Association and the American Association of Colleges of Nursing, signed a letter to leaders of the House and Senate appropriations committees in mid-May, after an earlier version of the budget was leaked. They expressed their opposition to the budget's elimination of the CDC's chronic disease center. The programs in the center "work with states and territories to prevent disease, detect it early, and manage it effectively," said the letter. Eliminating them "would destabilize public health systems at every level and jeopardize decades of progress." Global health The FY 2026 budget request eliminates the CDC's Global Health Center, and instead allocates $239 million toward global health protection, under the CDC's broader "CDC-Wide Activities" budget line. The Global Health Center spent $711 million in FY 2024. Defunding the center comes alongside the Trump administration's dismantling of the U.S. Agency for International Development and withdrawal from the World Health Organization. These actions will have consequences for Americans in addition to those abroad, said Janeen Madan Keller, deputy director of the Global Health Policy Program at the Center for Global Development, a think tank based in Washington, D.C. "From our own experience with epidemics and pandemics, we know that infectious diseases do not respect borders," Keller said. "It's really important that we have the ability to stop these outbreaks in their tracks before they reach our border." Other programs AHA consolidates federal HIV/AIDS prevention and research. It cuts $794 million of the CDC's funding for domestic HIV/AIDS prevention and takes over HIV/AIDS programs from other agencies. In total, AHA allocates a combined $2.7 billion to the virus and resulting disease — almost $1 billion less than those programs were appropriated in FY 2024. Other centers moved from the CDC include its centers for Birth Defects, Developmental Disabilities, Disability and Health, Injury Prevention and Control, and Occupational Safety and Health. Some of the funding from these centers has been moved to broader programs within AHA, according to the budget proposal. Before the budget is passed, it will be reviewed by congressional subcommittees before the House and Senate prepare their own budget resolutions later this year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store